/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. ("Silk Road" or the "Company") (NASDAQ: SILK). Such.
NEW YORK, Nov. 3, 2023 /PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Silk Road Medical, Inc. . Such investors are advised to contact Robert S. Willoughby at.
Easing access to Alzheimer s diagnostic tests is critical in light of recent approvals of drugs to reduce amyloid plaque. But questions remain regarding equitable access.